NASDAQ:CDLX - Cardlytics Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$22.34 -1.04 (-4.45 %)
(As of 07/16/2018 08:41 AM ET)
Previous Close$23.38
Today's Range$22.16 - $23.81
52-Week Range$11.10 - $25.71
Volume59,577 shs
Average Volume123,206 shs
Market Capitalization$452.70 million
P/E Ratio-2.79
Dividend YieldN/A
BetaN/A
Cardlytics logoCardlytics, Inc. operates a purchase intelligence platform in the United States and the United Kingdom. It operates in two segments, Cardlytics Direct and Other Platform Solutions. The company's platform is the Cardlytics Direct solution, a proprietary native bank advertising channel that enables marketers to reach consumers through their trusted and frequently visited online and mobile banking channels. It also provides solutions that enable marketers and marketing service providers to leverage the power of purchase intelligence outside the banking channel. The company was founded in 2008 and is headquartered in Atlanta, Georgia.

Receive CDLX News and Ratings via Email

Sign-up to receive the latest news and ratings for CDLX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Computer programming, data processing, & other computer related
Sub-IndustryN/A
SectorBusiness Services
SymbolNASDAQ:CDLX
CUSIPN/A
Phone888-798-5802

Debt

Debt-to-Equity Ratio0.81
Current Ratio1.68
Quick Ratio1.68

Price-To-Earnings

Trailing P/E Ratio-2.79
Forward P/E Ratio-11.34
P/E GrowthN/A

Sales & Book Value

Annual Sales$130.37 million
Price / Sales3.47
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Employees342
Outstanding Shares20,260,000
Market Cap$452.70

The Truth About Cryptocurrencies

Cardlytics (NASDAQ:CDLX) Frequently Asked Questions

What is Cardlytics' stock symbol?

Cardlytics trades on the NASDAQ under the ticker symbol "CDLX."

How were Cardlytics' earnings last quarter?

Cardlytics Inc (NASDAQ:CDLX) released its quarterly earnings results on Thursday, May, 10th. The company reported ($0.60) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.62) by $0.02. The company had revenue of $32.71 million for the quarter, compared to analyst estimates of $29.74 million. View Cardlytics' Earnings History.

What price target have analysts set for CDLX?

6 brokerages have issued 1-year target prices for Cardlytics' stock. Their predictions range from $19.00 to $25.00. On average, they expect Cardlytics' stock price to reach $22.40 in the next year. This suggests a possible upside of 0.3% from the stock's current price. View Analyst Ratings for Cardlytics.

What is the consensus analysts' recommendation for Cardlytics?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cardlytics in the last year. There are currently 1 hold rating and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy."

Who are some of Cardlytics' key competitors?

Who are Cardlytics' key executives?

Cardlytics' management team includes the folowing people:
  • Mr. Scott D. Grimes, Co-Founder, CEO & Director (Age 55)
  • Ms. Lynne Marie Laube, Co-Founder, COO & Director (Age 49)
  • Mr. David Evans, CFO & Head of Corp. Devel.
  • Mr. Sathish Gaddipati, Chief Technology Officer (Age 51)
  • Mr. Kirk L. Somers, Chief Legal & Privacy Officer (Age 53)

When did Cardlytics IPO?

(CDLX) raised $76 million in an IPO on Friday, February 9th 2018. The company issued 5,400,000 shares at $13.00-$15.00 per share. BofA Merrill Lynch and J.P. Morgan acted as the underwriters for the IPO and Wells Fargo Securities, SunTrust Robinson Humphrey, Raymond James and KeyBanc Capital Markets were co-managers.

When does Cardlytics' lock-up period expire?

Cardlytics' lock-up period expires on Wednesday, August 8th. Cardlytics had issued 5,400,000 shares in its IPO on February 9th. The total size of the offering was $70,200,000 based on an initial share price of $13.00. Shares of the company owned by major shareholders and company insiders will be eligible for trade following the end of the lock-up period.

Has Cardlytics been receiving favorable news coverage?

Headlines about CDLX stock have trended somewhat positive on Monday, Accern Sentiment reports. The research firm identifies positive and negative media coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Cardlytics earned a media sentiment score of 0.10 on Accern's scale. They also gave media stories about the company an impact score of 46.11 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the immediate future.

How do I buy shares of Cardlytics?

Shares of CDLX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Cardlytics' stock price today?

One share of CDLX stock can currently be purchased for approximately $22.34.

How big of a company is Cardlytics?

Cardlytics has a market capitalization of $452.70 million and generates $130.37 million in revenue each year. The company earns $-19,640,000.00 in net income (profit) each year or ($8.02) on an earnings per share basis. Cardlytics employs 342 workers across the globe.

How can I contact Cardlytics?

Cardlytics' mailing address is 675 PONCE DE LEON AVENUE NE SUITE 6000, ATLANTA GA, 30308. The company can be reached via phone at 888-798-5802 or via email at [email protected]


MarketBeat Community Rating for Cardlytics (NASDAQ CDLX)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  30 (Vote Outperform)
Underperform Votes:  34 (Vote Underperform)
Total Votes:  64
MarketBeat's community ratings are surveys of what our community members think about Cardlytics and other stocks. Vote "Outperform" if you believe CDLX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CDLX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/16/2018 by MarketBeat.com Staff

Featured Article: What does RSI mean?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.